184 related articles for article (PubMed ID: 21368746)
1. Peroxisome proliferator-activated receptor-α is renoprotective in doxorubicin-induced glomerular injury.
Zhou Y; Kong X; Zhao P; Yang H; Chen L; Miao J; Zhang X; Yang J; Ding J; Guan Y
Kidney Int; 2011 Jun; 79(12):1302-11. PubMed ID: 21368746
[TBL] [Abstract][Full Text] [Related]
2. PPAR-α transcriptional activity is required to combat doxorubicin-induced podocyte injury in mice.
Mori K; Mukoyama M; Nakao K
Kidney Int; 2011 Jun; 79(12):1274-6. PubMed ID: 21625258
[TBL] [Abstract][Full Text] [Related]
3. Interactions of PPAR α and GLUT4 in DOCA/salt-induced renal injury in mice.
Ighodaro I; Eric OK; Adebayo O
Niger J Physiol Sci; 2013 Dec; 28(2):127-33. PubMed ID: 24937386
[TBL] [Abstract][Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury.
Yuan Y; Huang S; Wang W; Wang Y; Zhang P; Zhu C; Ding G; Liu B; Yang T; Zhang A
Kidney Int; 2012 Oct; 82(7):771-89. PubMed ID: 22648295
[TBL] [Abstract][Full Text] [Related]
5. Apigenin ameliorates doxorubicin-induced renal injury via inhibition of oxidative stress and inflammation.
Wu Q; Li W; Zhao J; Sun W; Yang Q; Chen C; Xia P; Zhu J; Zhou Y; Huang G; Yong C; Zheng M; Zhou E; Gao K
Biomed Pharmacother; 2021 May; 137():111308. PubMed ID: 33556877
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.
Dai C; Saleem MA; Holzman LB; Mathieson P; Liu Y
Kidney Int; 2010 Jun; 77(11):962-73. PubMed ID: 20375988
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of sinomenine against doxorubicin-induced nephrosis in rats.
Zhang J; Hu R; Xia ZK; Ren XG; Zhang LW; Liang YH; Liu GL
J Asian Nat Prod Res; 2012; 14(7):678-87. PubMed ID: 22582804
[TBL] [Abstract][Full Text] [Related]
8. Loss of Roundabout Guidance Receptor 2 (Robo2) in Podocytes Protects Adult Mice from Glomerular Injury by Maintaining Podocyte Foot Process Structure.
Pisarek-Horowitz A; Fan X; Kumar S; Rasouly HM; Sharma R; Chen H; Coser K; Bluette CT; Hirenallur-Shanthappa D; Anderson SR; Yang H; Beck LH; Bonegio RG; Henderson JM; Berasi SP; Salant DJ; Lu W
Am J Pathol; 2020 Apr; 190(4):799-816. PubMed ID: 32220420
[TBL] [Abstract][Full Text] [Related]
9. Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease.
George B; Verma R; Soofi AA; Garg P; Zhang J; Park TJ; Giardino L; Ryzhova L; Johnstone DB; Wong H; Nihalani D; Salant DJ; Hanks SK; Curran T; Rastaldi MP; Holzman LB
J Clin Invest; 2012 Feb; 122(2):674-92. PubMed ID: 22251701
[TBL] [Abstract][Full Text] [Related]
10. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.
Yamashita M; Yoshida T; Suzuki S; Homma K; Hayashi M
Clin Exp Nephrol; 2017 Feb; 21(1):16-26. PubMed ID: 27089875
[TBL] [Abstract][Full Text] [Related]
11. Mice with a
Cunanan J; Rajyam SS; Sharif B; Udwan K; Rana A; De Gregorio V; Ricardo S; Elia A; Brooks B; Weins A; Pollak M; John R; Barua M
Am J Physiol Renal Physiol; 2024 May; 326(5):F704-F726. PubMed ID: 38482556
[TBL] [Abstract][Full Text] [Related]
12. Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia.
Chen Y; Chen H; Birnbaum Y; Nanhwan MK; Bajaj M; Ye Y; Qian J
Diab Vasc Dis Res; 2017 Mar; 14(2):152-162. PubMed ID: 28111985
[TBL] [Abstract][Full Text] [Related]
13. IL-1 receptor signaling in podocytes limits susceptibility to glomerular damage.
Ren J; Lu X; Hall G; Privratsky JR; Robson MJ; Blakely RD; Crowley SD
Am J Physiol Renal Physiol; 2022 Feb; 322(2):F164-F174. PubMed ID: 34894725
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor {alpha} agonism prevents renal damage and the oxidative stress and inflammatory processes affecting the brains of stroke-prone rats.
Gelosa P; Banfi C; Gianella A; Brioschi M; Pignieri A; Nobili E; Castiglioni L; Cimino M; Tremoli E; Sironi L
J Pharmacol Exp Ther; 2010 Nov; 335(2):324-31. PubMed ID: 20671072
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of cyclooxygenase-2 predisposes to podocyte injury.
Cheng H; Wang S; Jo YI; Hao CM; Zhang M; Fan X; Kennedy C; Breyer MD; Moeckel GW; Harris RC
J Am Soc Nephrol; 2007 Feb; 18(2):551-9. PubMed ID: 17202413
[TBL] [Abstract][Full Text] [Related]
16. Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis.
Tanaka Y; Kume S; Araki S; Isshiki K; Chin-Kanasaki M; Sakaguchi M; Sugimoto T; Koya D; Haneda M; Kashiwagi A; Maegawa H; Uzu T
Kidney Int; 2011 Apr; 79(8):871-82. PubMed ID: 21270762
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of Fenofibrate in renal ischemia reperfusion injury: Involved in suppressing kinase 2 (JAK2)/transcription 3 (STAT3)/p53 signaling activation.
Lv J; Wang X; Liu SY; Liang PF; Feng M; Zhang LL; Xu AP
Pathol Biol (Paris); 2015 Dec; 63(6):236-42. PubMed ID: 26343046
[TBL] [Abstract][Full Text] [Related]
18. Peroxisomal proliferator-activated receptor-alpha protects renal tubular cells from doxorubicin-induced apoptosis.
Lin H; Hou CC; Cheng CF; Chiu TH; Hsu YH; Sue YM; Chen TH; Hou HH; Chao YC; Cheng TH; Chen CH
Mol Pharmacol; 2007 Nov; 72(5):1238-45. PubMed ID: 17671096
[TBL] [Abstract][Full Text] [Related]
19. PPAR-gamma agonist protects podocytes from injury.
Kanjanabuch T; Ma LJ; Chen J; Pozzi A; Guan Y; Mundel P; Fogo AB
Kidney Int; 2007 Jun; 71(12):1232-9. PubMed ID: 17457378
[TBL] [Abstract][Full Text] [Related]
20. Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes.
Takahashi Y; Ikezumi Y; Saitoh A
Nephrology (Carlton); 2017 Jan; 22(1):49-57. PubMed ID: 26833819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
